Ovarian cancer is particularly dangerous because of the high risk of metastasis. Researchers have developed a molecule capable, under light control, of attaching itself specifically to peritoneal metastases and destroying them by oxidizing them. Published in the Journal of Controlled Release, this work opens up a new therapeutic avenue.